OPTIC NEUROPATHY IN PATIENTS WITH GLIOBLASTOMA RECEIVING BEVACIZUMAB

被引：4
|
作者：
Chamberlain, Marc C.
Raizer, Jeffrey
机构：
来源：
NEUROLOGY | 2010年 / 75卷 / 03期
关键词：
D O I：
10.1212/WNL.0b013e3181e79567
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：289 / 290
页数：5
相关论文
共 50 条
  • [21] Anti-VEGF bevacizumab (Avastin®) for radiation optic neuropathy
    Finger, Paul T.
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 143 (02) : 335 - 338
  • [22] REAL-WORLD ANALYSIS OF OUTCOMES OF PATIENTS RECEIVING BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA IN BRITISH COLUMBIA
    Chahal, Manik
    Thiessen, Brian
    [J]. NEURO-ONCOLOGY, 2021, 23 : 157 - 157
  • [23] The prognosis for patients with newly diagnosed glioblastoma receiving bevacizumab combination therapy: a meta-analysis
    Liao, Ke-Li
    Huang, Song
    Wu, Yu-Peng
    [J]. ONCOTARGETS AND THERAPY, 2018, 11 : 3513 - 3520
  • [24] Anterior Ischemic Optic Neuropathy After Intravitreal Injection of Bevacizumab
    Hosseini, Hamid
    Razeghinejad, Mohammad Reza
    [J]. JOURNAL OF NEURO-OPHTHALMOLOGY, 2009, 29 (02) : 160 - 161
  • [25] SEIZURE CONTROL BY BEVACIZUMAB IN GLIOBLASTOMA PATIENTS
    Hertler, Caroline
    Seystahl, Katharina
    Le Rhun, Emilie
    Wirsching, Georg
    Roth, Patrick
    Weller, Michael
    Gramatzki, Dorothee
    [J]. NEURO-ONCOLOGY, 2022, 24 : 111 - 111
  • [26] Bevacizumab: is the lower the better for glioblastoma patients?
    Sirven-Villaros, L.
    Bourg, V.
    Mondot, L.
    Burel-Vandenbos, F.
    Fontaine, D.
    Frenay, M.
    Lebrun-Frenay, C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 916 - 916
  • [27] BEVACIZUMAB DISCONTINUATION AND BEVACIZUMAB RE-CHALLENGE IN GLIOBLASTOMA PATIENTS
    Bonnet, C.
    Cartalat-Carel, S.
    Thomas, L.
    Joubert, B.
    Meyronet, D.
    D'Hombres, A.
    Jouanneau, E.
    Guyotat, J.
    Honnorat, J.
    Ducray, F.
    [J]. NEURO-ONCOLOGY, 2016, 18 : 51 - 51
  • [28] Real-world analysis of outcomes of patients receiving bevacizumab for recurrent glioblastoma in British Columbia.
    Chahal, Manik
    Harrison, Rebecca A.
    Thiessen, Brian Arthur
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [29] Value of [18F]-FDG positron emission tomography in patients with recurrent glioblastoma receiving bevacizumab
    Graham, Maya S.
    Krebs, Simone
    Bale, Tejus
    Domfe, Kwaku
    Lobaugh, Stephanie M.
    Zhang, Zhigang
    Dunphy, Mark P.
    Kaley, Thomas
    Young, Robert J.
    [J]. NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)
  • [30] Effect of angiotensin system inhibitors on survival in newly diagnosed glioma patients and recurrent glioblastoma patients receiving chemotherapy and/or bevacizumab
    Victor A. Levin
    James Chan
    Meenal Datta
    Jennie L. Yee
    Rakesh K. Jain
    [J]. Journal of Neuro-Oncology, 2017, 134 : 325 - 330
12345